November 19, 2025
1 min read

Celltrion to widen US manufacturing reach with $478M investment at former Lilly plant

Two months after Celltrion bought a U.S. manufacturing facility from Eli Lilly for $330 million, the South Korean biosimilar specialist said it will spend another 700 billion won ($478 million) to upgrade the plant.

Leave a Reply

Your email address will not be published.

Previous Story

California Nutrition Center has a lot to be thankful for

Next Story

Which Gen Zers are more likely to overeat junk food

Previous Story

California Nutrition Center has a lot to be thankful for

Next Story

Which Gen Zers are more likely to overeat junk food

Latest from Blog

ROFI Drives New Approach to Crop Nutrition

With input costs continuing to pressure farm budgets, some growers are making difficult decisions to reduce fertilizer application rates. While that strategy may ease upfront expenses, it is also accelerating a broader
Go toTop